Websites Owned by [email protected]:

  • mCSPC, nmCRPC and mCRPC Treatment Option | XTANDI® (enzalutamide) - Safety Info

    See the risks & benefits of XTANDI® (enzalutamide) for the treatment of patients with mCSPC, nonmetastatic and metastatic castration-resistant prostate cancer (nmCRPC) & (mCRPC).